Oral versions of GLP-1s on the horizon

With benefits beyond glucose control for the “new kid on the block” in diabetes management, leading researcher foreshadows oral versions with less side effects New versions of GLP-1 receptor agonists (RA) are in the works and could be coming to Australia soon, says Deputy Director of Clinical and Population Health, Baker Heart and Diabetes Institute,